Aarti Pharmalabs Grants 57,600 Stock Options

This is a regulatory disclosure submitted to the BSE Limited and the National Stock Exchange of India Limited in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The disclosure intimates the exchanges that the Nomination and Remuneration Committee of the company's Board of Directors approved the grant of stock options at its meeting held on Monday, May 25, 2026.

Key Quantitative Figures

• Number of Options Granted: 57,600 (Fifty Seven Thousand Six Hundred)
• Exercise Price: ₹5 (Rupees Five) per option

Parties Involved & Plan Details

• The grant is made under the 'APL Performance Stock Option Plan- 2023' (PSOP 2023).
• The options have been granted to certain eligible employees of Aarti Pharmalabs Limited and its subsidiary company.
• The grant is subject to the provisions of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.